The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151'
PHASE1CompletedINTERVENTIONAL
Enrollment
46
Participants
Timeline
Start Date
March 21, 2025
Primary Completion Date
April 25, 2025
Study Completion Date
May 8, 2025
Conditions
Gastric Ulcer
Interventions
DRUG
AD-115A, AD-1151
AD-115A , AD-1151 Oral Tablet
Trial Locations (1)
Unknown
H PLUS YANGJI HOSPITAL, Seoul,, Seoul
All Listed Sponsors
lead
Addpharma Inc.
INDUSTRY
NCT06902818 - The Study Compare and Evaluate the Safety and PK Data of a Single Dose Administration of 'AD-115A' or 'AD-1151' | Biotech Hunter | Biotech Hunter